HOLLISTON, Mass., — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its wholly-owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc., or HART, has filed an initial Form 10 Registration Statement (“Form 10”) with the […]
Bina Technologies, a company aiming to make genome processing faster and cheaper, has accepted $1.75 million for its Series B round, which included $6.25 million from Sierra Ventures. Behind the new capital are Jerry Yang of AME Cloud Ventures and Mohsen Moazami of Columbus Nova Technology Partners.
Venlo, The Netherlands, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 26, 2013, and to purchase shares in the Company up to a total of […]
Redwood City, CA – Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced that they have added to their Series B financing round with $1.75M in additional funding, bringing their total Series B round to $8M. The additional funding was led by Mohsen Moazami at Columbus Nova Technology Partners (CNTP) and […]
MADISON, WIS. — Cellular Dynamics International, Inc. (Nasdaq: ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced the closing of its previously announced initial public offering of 3,846,000 shares of common stock at a price to the public of $12.00 per share. The underwriters have a […]
Venture capital fund manager Mercia Fund Management (MFM) has announced £150,000 of funding in Oxford Genetics Ltd. The new biotechnology company is behind SnapFast™ – a system that simplifies the purchase of synthetic DNA molecules (plasmids). CEO of Oxford Genetics, Dr Ryan Cawood, invented the SnapFast™ system and likens it to “Lego for DNA”. Historically, […]
MADISON, WIS., — Cellular Dynamics International, Inc., a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced the pricing of its initial public offering of 3,846,000 shares of common stock at a price to the public of $12.00 per share. The shares are expected to begin trading on […]
Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 49.5 cents per common share, payable on September 30, 2013 to holders of record on September 9, 2013. The indicated annual dividend rate is $1.98 per share.
MADISON, Wisconsin –– DNASTAR® announced that it received a Phase II SBIR grant award from the National Institutes of Health entitled, “Association Analysis Software for Mining Clinical Next-Gen Sequencing Data”. This is the second phase of a project initially funded in 2012 to support the company’s research and development aimed at expanding its industry-leading sequence […]
Wellington, New Zealand: Magritek, world leading providers of benchtop NMR and MRI instruments, today announced that a major New Zealand private equity investor has acquired a 12% stake in the company for a non-disclosed sum. The investor is Rangatira Limited, a diversified investment company with investment funds of around $200 million. The transaction will strengthen […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
